A recent study found that intravenous immuneglobulines (IVIg) as a promising candidate for the treatment of severe post-COVID refractory to supportive measures. Patients receiving IVIg and supportive measures reported a substantially greater relief of symptoms than patients receiving supportive therapy alone. Interestingly, especially the most restricti…
© 2025 Danilo Buonsenso
Substack is the home for great culture